Elicera Therapeutics AB Statistics

Total Valuation

STO:ELIC has a market cap or net worth of SEK 261.12 million. The enterprise value is 215.47 million.

Market Cap	261.12M
Enterprise Value	215.47M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:ELIC has 48.54 million shares outstanding. The number of shares has increased by 77.56% in one year.

Current Share Class	48.54M
Shares Outstanding	48.54M
Shares Change (YoY)	+77.56%
Shares Change (QoQ)	+4.15%
Owned by Insiders (%)	26.76%
Owned by Institutions (%)	13.28%
Float	34.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	60.56
PB Ratio	7.97
P/TBV Ratio	7.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.49
EV / Sales	49.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.40

Current Ratio	3.40
Quick Ratio	3.40
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-910.87

Financial Efficiency

Return on equity (ROE) is -58.27% and return on invested capital (ROIC) is -37.90%.

Return on Equity (ROE)	-58.27%
Return on Assets (ROA)	-27.79%
Return on Invested Capital (ROIC)	-37.90%
Return on Capital Employed (ROCE)	-59.59%
Revenue Per Employee	2.16M
Profits Per Employee	-9.38M
Employee Count	2
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +313.85% in the last 52 weeks. The beta is 0.43, so STO:ELIC's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+313.85%
50-Day Moving Average	5.34
200-Day Moving Average	2.97
Relative Strength Index (RSI)	47.03
Average Volume (20 Days)	293,489

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:ELIC had revenue of SEK 4.31 million and -18.75 million in losses. Loss per share was -0.53.

Revenue	4.31M
Gross Profit	4.31M
Operating Income	-19.52M
Pretax Income	-18.75M
Net Income	-18.75M
EBITDA	-19.51M
EBIT	-19.52M
Loss Per Share	-0.53

Full Income Statement

Balance Sheet

The company has 45.65 million in cash and n/a in debt, giving a net cash position of 45.65 million or 0.94 per share.

Cash & Cash Equivalents	45.65M
Total Debt	n/a
Net Cash	45.65M
Net Cash Per Share	0.94
Equity (Book Value)	32.75M
Book Value Per Share	0.67
Working Capital	32.75M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-14.94M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-452.68%
Pretax Margin	-434.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:ELIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-77.56%
Shareholder Yield	n/a
Earnings Yield	-7.18%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:ELIC has an Altman Z-Score of 0.16 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.16
Piotroski F-Score	1